EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Acute inflammation induced by the Escherichia coli lipopolysaccharide considerably increases the systemic and brain exposure of olanzapine after oral administration in mice

Jan Hubeňák, Martin Mžik, Hana Laštůvková, David Bayer, Lenka Jandová, Jolana Schreiberová, Ctirad Andrýs, Stanislav Mičuda, Jiří Masopust, Jaroslav Chládek iD

International Journal of Neuropsychopharmacology · 2025

DOI: 10.1093/ijnp/pyaf036 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Neuropsychopharmacology, 2025. Verfasst von Jan Hubeňák und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, University Hospital and the Faculty of Medicine, Charles University, Hradec Kralove, Czech Republic. Hauptthemen laut MEDLINE: Brain, Benzodiazepines, Antipsychotic Agents, Inflammation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education, Youth, and Sports of the Czech Republic, University of Hradec Králové, Charles Universit.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

A detailed understanding of alterations in olanzapine pharmacokinetics during acute inflammatory states, associated with infections, remains lacking. This study aimed to investigate the impact of endotoxemia on the pharmacokinetics of olanzapine and desmethylolanzapine (DMO) in mice.

Methods

C57BL/6N mice received an intraperitoneal injection of lipopolysaccharide (LPS, 5 mg/kg) or saline (controls), followed 24 hours later by single oral or intravenous doses of olanzapine or intravenous DMO. Concentrations and unbound fractions of olanzapine and DMO were measured in the plasma and brain homogenates.

Results

In LPS-injected mice, the area under the concentration–time curve (AUCs) for olanzapine increased 3.8-fold in the plasma and 5.2-fold in brain homogenates, in consequence of a higher absolute bioavailability of olanzapine (+200%), a lower plasma clearance (−34%), and a higher brain penetration ratio for the unbound drug relative to controls (Kp,uu,brain 6.2 vs. 4.1). LPS attenuated the hepatic mRNA expression of cytochrome P450 1A2 and the metabolism of olanzapine to DMO. However, the AUC of plasma DMO increased by 140% due to a 4.8-fold decrease in the plasma clearance of DMO. The brain penetration of DMO was minimal (Kp,uu,brain ≤ 0.051). The LPS-injected mice exhibited a downregulation of the hepatic and ileal mRNA expression of P-glycoprotein (Abcb1a), whereas the expression of Abcb1a and Abcb1b in the brain was upregulated.

Conclusions

Endotoxemia notably increases olanzapine concentrations in the plasma and brain following oral administration in mice. Further studies should clarify whether altered pharmacokinetics results in adverse effects in acutely infected patients taking oral olanzapine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BrainBenzodiazepinesAntipsychotic AgentsInflammationEndotoxemiaAnimalsOlanzapineLipopolysaccharidesAdministration, OralMice, Inbred C57BLMaleMice

Stichwörter der Autor:innen

brain penetrationendotoxemialipopolysaccharideolanzapinepharmacokinetics

Substanzen

OlanzapineLipopolysaccharidesBenzodiazepinesAntipsychotic Agents

Autor:innen und Institutionen

  • Department of Psychiatry, University Hospital and the Faculty of Medicine, Charles University, Hradec Kralove, Czech Republic.
  • Department of Clinical Biochemistry and Diagnostics, University Hospital and the Faculty of Medicine, Charles University, Hradec Kralove, Czech Republic.
  • Department of Pharmacology, Faculty of Medicine, Charles University, Hradec Kralove, Czech Republic.
  • Faculty Vivarium, Faculty of Medicine, Charles University, Hradec Kralove, Czech Republic.
  • Department of Clinical Immunology and Allergology, University Hospital and the Faculty of Medicine, Charles University, Hradec Kralove, Czech Republic.

ORCID-Profile: Jaroslav Chládek

Förderung

  • Ministry of Education, Youth, and Sports of the Czech Republic
  • University of Hradec Králové
  • Charles Universit

Zitieren

APA

Hubeňák, J., Mžik, M., Laštůvková, H., Bayer, D., Jandová, L., Schreiberová, J., Andrýs, C., Mičuda, S., Masopust, J., & Chládek, J. (2025). Acute inflammation induced by the Escherichia coli lipopolysaccharide considerably increases the systemic and brain exposure of olanzapine after oral administration in mice. International Journal of Neuropsychopharmacology. https://doi.org/10.1093/ijnp/pyaf036

Vancouver

Hubeňák J, Mžik M, Laštůvková H, Bayer D, Jandová L, Schreiberová J, et al. Acute inflammation induced by the Escherichia coli lipopolysaccharide considerably increases the systemic and brain exposure of olanzapine after oral administration in mice. International Journal of Neuropsychopharmacology. 2025. doi:10.1093/ijnp/pyaf036

BibTeX
@article{Hubek2025,
  author = {Hubeňák, Jan and Mžik, Martin and Laštůvková, Hana and Bayer, David and Jandová, Lenka and Schreiberová, Jolana and Andrýs, Ctirad and Mičuda, Stanislav and Masopust, Jiří and Chládek, Jaroslav},
  title = {Acute inflammation induced by the Escherichia coli lipopolysaccharide considerably increases the systemic and brain exposure of olanzapine after oral administration in mice},
  journal = {International Journal of Neuropsychopharmacology},
  year = {2025},
  doi = {10.1093/ijnp/pyaf036}
}
Kostenlos starten →